The Medicines for Human Use (Clinical Trials) Amendment Regulations 2006

Amendment of Schedule 9 to the principal Regulations

This section has no associated Explanatory Memorandum

32.  In Schedule 9 to the principal Regulations (modifications of the enforcement provisions of the Act subject to which those provisions are applied for the purposes of these Regulations), in paragraph 5 for “England and Wales” substitute “Northern Ireland”.